Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study

BACKGROUND: Diabetes mellitus is a recognized risk factor for esophageal squamous cell carcinomas (ESCC), and metformin is a recognized protective factor for some gastrointestinal tumors. But knowledge is limited regarding the effect of metformin on survival outcome of ESCC patients with type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Huang-He, Fu, Jun-Hui, Hao, Zhe-Xue, Wu, He-Fang, Zhong, Qiang, Wang, Fan, Liu, Hang-Hui, Gu, Xiang-Sen, Wang, Bin, Huang, Hao-Da, Li, Zhuo-Yi, He, Jian-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138989/
https://www.ncbi.nlm.nih.gov/pubmed/32274150
http://dx.doi.org/10.21037/jtd.2019.12.98

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138989/
https://www.ncbi.nlm.nih.gov/pubmed/32274150
http://dx.doi.org/10.21037/jtd.2019.12.98

Ejemplares similares